Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis

被引:92
|
作者
Barth, H [1 ]
Preiss, JC [1 ]
Hofmann, F [1 ]
Aktories, K [1 ]
机构
[1] Univ Freiburg, Inst Pharmakol & Toxikol, D-79104 Freiburg, Germany
关键词
D O I
10.1074/jbc.273.45.29506
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The actin ADP-ribosylating Clostridium botulinum C2 toxin is a binary toxin composed of the binding component C2II and the enzyme component C2I. C2I ADP-ribosylates G-actin at arginine 177, resulting in the depolymerization of the actin cytoskeleton. Here, we studied the structure-function relationship of C2I by site-directed mutagenesis. Exchange of Glu(389) to glutamine caused the complete loss of ADP-ribosyltransferase and NAD-glycohydrolase activities of C2I. In contrast, exchange of Glu(387) to glutamine blocked ADP-ribosyltransferase but not NAD-glycohydrolase activity. Whereas photoaffinity labeling of the double mutant E387Q/E389Q C2I with [carbonyl-C-14]NAD was blocked, labeling of the single C2I mutants was reduced (E389Q) or not changed (E387Q). Exchange of the STS motif (amino acid residues 348-350) of C2I caused a decrease in transferase activity by more than 99 (S348A) and 90% (T349V), or did not affect activity (S350A). Exchange of Arg(299) and Arg(300) to lysine reduced transferase activity to <0.1 and similar to 35% of wild-type activity. The data indicate that the amino acid residues Glu(389), Glu(387), Ser(348), and Arg(299), which are conserved in various prokaryotic and eukaryotic arginine-modifying ADP-ribosyltransferases, are essential for ADP-ribosyltransferase activity of the enzyme component of C. botulinum C2 toxin.
引用
收藏
页码:29506 / 29511
页数:6
相关论文
共 50 条
  • [21] SITE-DIRECTED MUTAGENESIS OF THE CATALYTIC SITE OF F1-ATPASE
    PARSONAGE, D
    SENIOR, AE
    BIOPHYSICAL JOURNAL, 1987, 51 (02) : A242 - A242
  • [22] NAD-BINDING SITE OF THE C3-LIKE ADP-RIBOSYLTRANSFERASE FROM CLOSTRIDIUM-LIMOSUM
    JUNG, M
    JUST, I
    VANDAMME, J
    VANDEKERCKHOVE, J
    AKTORIES, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (31) : 23215 - 23218
  • [23] ALTERATION OF CATALYTIC PROPERTIES OF CHYMOSIN BY SITE-DIRECTED MUTAGENESIS
    SUZUKI, J
    SASAKI, K
    SASAO, Y
    HAMU, A
    KAWASAKI, H
    NISHIYAMA, M
    HORINOUCHI, S
    BEPPU, T
    PROTEIN ENGINEERING, 1989, 2 (07): : 563 - 569
  • [24] SITE-DIRECTED MUTAGENESIS OF HISTIDINE-RESIDUES IN CLOSTRIDIUM-PERFRINGENS ALPHA-TOXIN
    NAGAHAMA, M
    OKAGAWA, Y
    NAKAYAMA, T
    NISHIOKA, E
    SAKURAI, J
    JOURNAL OF BACTERIOLOGY, 1995, 177 (05) : 1179 - 1185
  • [25] Site-directed mutagenesis studies on the zinc-binding domain of Clostridium perfringens alpha toxin
    Nagahama, M
    Nakayama, T
    Kobayashi, K
    Sakurai, J
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1995, 48 (5-6): : 265 - 266
  • [26] Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile
    Gonçalves, C
    Decré, D
    Barbut, F
    Burghoffer, B
    Petit, JC
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 1933 - 1939
  • [27] Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis
    Wang, Xiaogang
    Xu, Mingkai
    Zhang, Huiwen
    Liu, Jie
    Li, Xu
    Zhang, Chenggang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) : 677 - 686
  • [28] Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis
    Xiaogang Wang
    Mingkai Xu
    Huiwen Zhang
    Jie Liu
    Xu Li
    Chenggang Zhang
    Cancer Immunology, Immunotherapy, 2009, 58
  • [29] Site-directed mutagenesis of the ganglioside binding domain of tetanus toxin
    Louch, HA
    Buczko, ES
    Venable, RM
    Vann, WF
    GLYCOBIOLOGY, 2000, 10 (10) : 1127 - 1127
  • [30] Interaction of Clostridium botulinum C3 ADP-ribosyltransferase with the Ras-related Ral protein
    Rex, G
    Just, I
    Hofmann, F
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 206 - 206